Earnings report for RadNet, Inc. (NASDAQ:RDNT) is anticipated on March, 14., RTT reports. Analysts predict $0.23 earnings per share. That’s $0.10 up or 76.92 % from 2018’s earnings of $0.13. This could hit $11.24 million profit for RDNT assuming the current $0.23 earnings per share will become reality. Wall Street sees 130.00 % EPS growth as of March, 14. RDNT is hitting $14.22 during the last trading session, after increased 1.64%.RadNet, Inc. has volume of 179,814 shares. Since February 16, 2018 RDNT has risen 28.62% and is uptrending. RDNT outperformed by 28.62% the S&P500.
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States.The firm is valued at $694.88 million. The Company’s services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology , fluoroscopy, and other related procedures, as well as multi-modality imaging services.Last it reported negative earnings. The firm also develops and sells computerized systems for the imaging industry, including picture archiving communications systems; and provides teleradiology services for remote interpretation of images on behalf of radiology groups, hospitals, and imaging center customers.
For more RadNet, Inc. (NASDAQ:RDNT) news brought out recently go to: Globenewswire.com, Nasdaq.com, Nasdaq.com, Seekingalpha.com or Fool.com. The titles are as follows: “RadNet, Inc. Announces Date of its Fourth Quarter 2017 Financial Results Conference Call – GlobeNewswire” brought out on February 28, 2018, “How The Pieces Add Up: IHF Targets $217 – Nasdaq” on December 31, 2018, “RadNet (RDNT) Lags Q3 Earnings and Revenue Estimates – Nasdaq” with a publish date: November 09, 2018, “RadNet to acquire Kern Radiology – Seeking Alpha” and the last “Here’s How RadNet Is Disrupting the Medical Imaging Market – The Motley Fool” with publication date: November 16, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.